The global bioweapons regime stands at a pivotal point where collaboration or conflict can determine the future of bioethical standards and international security. A recent sign pointing toward conflict is the North Atlantic Treaty Organization’s Biotechnology and Human Enhancement Technologies Strategy, which singles Russia as a bad actor. Such an approach not only risks […]
In our rapidly advancing world, biotechnology stands at the forefront of scientific progress. From gene editing and personalized medicine to anti-aging treatment and beyond, these breakthroughs promise to revolutionize healthcare, agriculture, and environmental conservation. However, as we celebrate these achievements, it’s crucial not to lose sight of a fundamental question: Are people’s rights safeguarded in […]
Note: This editorial accompanies The American Journal of Bioethics, Volume 23, Issue 11 (2023). Hundreds of articles have been written over the past several decades delineating the ethical tensions of health data commercialization, empirically querying the preferences of data contributors, and offering paths forward for ethical commercial health data privacy policies. In this issue, McCoy […]
See the following editorial in the November 2023 issue of The American Journal of Bioethics Recent advancements in large language models (LLMs) have ushered in a transformative phase in artificial intelligence (AI). Unlike conventional AI, LLMs excel in facilitating fluid human–computer dialogues. LLMs in chatbots and ChatGPT have proven capable of mimicking human-like interactions—meeting a demand […]
We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Privacy Policy. By closing this message, you are consenting to our use of cookies.
